Dr. Jinling Chen Discusses Life Science Strategies at WuXi AppTec
Thursday, 2 April 2026, 07:32
Life Science Innovations at WuXi AppTec
At WuXi AppTec’s Couvet site in Switzerland, an integrated CRDMO approach is being designed to accelerate the path from discovery to commercial manufacturing. Dr. Jinling Chen explains how combining advanced technologies and strategic methodologies allows the company to address a broad spectrum of biomedical challenges effectively.
Key Benefits of the CRDMO Model
- Rapid Development: Accelerates the manufacturing process.
- Cost Efficiency: Streamlines resource allocation.
- Innovative Solutions: Encourages unique approaches to complex problems.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.